Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.

Chervinsky P, Casale T, Townley R, Tripathy I, Hedgecock S, Fowler-Taylor A, Shen H, Fox H.

Ann Allergy Asthma Immunol. 2003 Aug;91(2):160-7.

PMID:
12952110
[PubMed - indexed for MEDLINE]
2.

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.

Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, Fox H, Surrey K.

Allergy. 2004 Jul;59(7):709-17.

PMID:
15180757
[PubMed - indexed for MEDLINE]
3.

Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.

Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, McAlary M, Fowler-Taylor A, Racine A, Gupta N, Fick R, Della Cioppa G; Omalizumab Seasonal Allergic Rhinitis Trail Group.

JAMA. 2001 Dec 19;286(23):2956-67.

PMID:
11743836
[PubMed - indexed for MEDLINE]
4.

Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.

Okubo K, Ogino S, Nagakura T, Ishikawa T.

Allergol Int. 2006 Dec;55(4):379-86.

PMID:
17130680
[PubMed - indexed for MEDLINE]
Free Article
5.

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD; Omalizumab 011 International Study Group.

Clin Exp Allergy. 2004 Apr;34(4):632-8.

PMID:
15080818
[PubMed - indexed for MEDLINE]
6.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
[PubMed - indexed for MEDLINE]
7.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
[PubMed - indexed for MEDLINE]
8.

Omalizumab: a review of its use in the management of allergic asthma.

Bang LM, Plosker GL.

Treat Respir Med. 2004;3(3):183-99. Review.

PMID:
15219177
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P.

J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.

PMID:
21636116
[PubMed - indexed for MEDLINE]
10.

Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).

Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM; QUALITX Study Investigators.

J Asthma. 2012 Apr;49(3):288-93. doi: 10.3109/02770903.2012.660297. Epub 2012 Feb 23.

PMID:
22356355
[PubMed - indexed for MEDLINE]
11.

Omalizumab: a monoclonal anti-IgE antibody.

Belliveau PP.

MedGenMed. 2005 Jan 27;7(1):27. Review.

PMID:
16369332
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.

Nagakura T, Ogino S, Okubo K, Sato N, Takahashi M, Ishikawa T.

Clin Exp Allergy. 2008 Feb;38(2):329-37. Epub 2007 Dec 7.

PMID:
18070163
[PubMed - indexed for MEDLINE]
13.

Omalizumab is effective in the long-term control of severe allergic asthma.

Lanier BQ, Corren J, Lumry W, Liu J, Fowler-Taylor A, Gupta N.

Ann Allergy Asthma Immunol. 2003 Aug;91(2):154-9.

PMID:
12952109
[PubMed - indexed for MEDLINE]
14.

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.

Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D, Davancaze T, Adelman D.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):243-8.

PMID:
15478383
[PubMed - indexed for MEDLINE]
15.

Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W.

Ann Intern Med. 2011 May 3;154(9):573-82. doi: 10.7326/0003-4819-154-9-201105030-00002.

PMID:
21536936
[PubMed - indexed for MEDLINE]
16.

Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.

Nayak A, Casale T, Miller SD, Condemi J, McAlary M, Fowler-Taylor A, Della Cioppa G, Gupta N.

Allergy Asthma Proc. 2003 Sep-Oct;24(5):323-9.

PMID:
14619332
[PubMed - indexed for MEDLINE]
17.

Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma.

Berger W, Gupta N, McAlary M, Fowler-Taylor A.

Ann Allergy Asthma Immunol. 2003 Aug;91(2):182-8.

PMID:
12952113
[PubMed - indexed for MEDLINE]
18.

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.

Cruz AA, Lima F, Sarinho E, Ayre G, Martin C, Fox H, Cooper PJ.

Clin Exp Allergy. 2007 Feb;37(2):197-207.

PMID:
17250692
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Omalizumab improves asthma-related quality of life in children with allergic asthma.

Lemanske RF Jr, Nayak A, McAlary M, Everhard F, Fowler-Taylor A, Gupta N.

Pediatrics. 2002 Nov;110(5):e55.

PMID:
12415061
[PubMed - indexed for MEDLINE]
20.

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.

Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U; DUAL study group.

Clin Exp Allergy. 2009 Feb;39(2):271-9. doi: 10.1111/j.1365-2222.2008.03121.x. Epub 2008 Oct 30.

PMID:
19016798
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk